J&J Intermediary Drug Rule Case Won't Get 2nd Look
By Sean McLernon ( August 17, 2012, 4:48 PM EDT) -- The Texas Supreme Court on Friday said it won't revisit a June ruling in which it reversed a $3.8 million award against a Johnson & Johnson unit and ruled for the fist time that prescription drugs fall under the so-called learned intermediary doctrine....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.